Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 08:11 am Sale |
2021-12-31 | 13G | GlycoMimetics, Inc. GLYC |
The Vanguard Group | 22,386 4.330% |
-3,307 (-12.87%) |
Filing History |
| 2021-07-12 08:29 am Sale |
2021-06-30 | 13G | GlycoMimetics, Inc. GLYC |
BlackRock Inc. BLK |
8,861 1.700% |
-17,303 (-66.13%) |
Filing History |
| 2021-02-16 08:24 am Sale |
2020-12-31 | 13G | GlycoMimetics, Inc. GLYC |
Camber Capital Management LP | 22,000 4.600% |
-13,000 (-37.14%) |
Filing History |
| 2021-02-12 3:42 pm Sale |
2020-12-31 | 13G | GlycoMimetics, Inc. GLYC |
EcoR1 Capital LLC | 0 0.000% |
-29,098 (Position Closed) |
Filing History |
| 2021-02-11 5:14 pm Purchase |
2020-12-31 | 13G | GlycoMimetics, Inc. GLYC |
BIOTECHNOLOGY VALUE FUND L P | 95,443 19.960% |
21,825 (+29.65%) |
Filing History |
| 2021-02-10 10:57 am Purchase |
2020-12-31 | 13G | GlycoMimetics, Inc. GLYC |
The Vanguard Group | 25,692 5.370% |
25,692 (New Position) |
Filing History |
| 2021-01-29 09:57 am Sale |
2020-12-31 | 13G | GlycoMimetics, Inc. GLYC |
BlackRock Inc. BLK |
26,165 5.500% |
-2,120 (-7.50%) |
Filing History |
| 2020-12-10 08:12 am Sale |
2020-11-30 | 13G | GlycoMimetics, Inc. GLYC |
Wellington Management Group LLP | 0 0.000% |
-48,319 (Position Closed) |
Filing History |